000 days 00 hours 00 minutes 00 seconds
Sessions being considered
- Delivering on gene therapies’ promise to patients
- Where will new therapies and vaccines come from?
- Vaccines and the future of pandemics: Lessons from Covid-19
- Infectious diseases – beyond Covid-19: A looming threat to global health
- Cardiovascular risk management: Prevention, wellness, diagnosis & social determinants of health
- Newer therapies for oncology and autoimmune disease
- Future pathways in translational medicine: Academic industry collaborations in CNS diseases
- Orchestrating patient–centricity from molecule to market: How will computing technology transform drug discovery and therapies?
*The Galien Forum and Prix Galien USA Ceremony will take place on October 28, 2021, though in order to ensure the safety of all participants our format may shift in keeping with COVID-19-related guidelines issued by the Centers for Disease Control and Prevention (CDC) and New York City authorities. The Galien Foundation is considering and planning for multiple scenarios, including a smaller in-person event with digital access, a partially virtual event, and a completely virtual event. Updates will be posted and shared with our network via email as soon as they are confirmed.
Confirmed speakers*
Co-chairs:
Sue Desmond-Hellmann, MD, MPh, Prix Galien USA Committee Chair; Former Chief Executive Officer of the Bill & Melinda Gates Foundation
Michael Rosenblatt, Prix Galien USA Committee Member; Chief Medical Officer of Flagship Pioneering
Stephane Bancel, CEO, Moderna
Albert Bourla, CEO, Pfizer
Robert Bradway, Chairman & CEO, Amgen
Giovanni Caforio, Chairman & CEO, Bristol Myers Squibb
Mikael Dolsten, Chief Scientific Officer & President, WW Research, Development and Medical, Pfizer
Ken Frazier, CEO, Merck & Co.
Belen Garijo, Vice Chair of the Executive Board & Deputy CEO, Merck KGaA
Laurie Glimcher, President & CEO, Dana-Farber Cancer Institute, Professor of Medicine, Harvard Medical School
Alex Gorsky, CEO, J&J
Sebastian Guth, President of Pharmaceuticals, Americas Region, Bayer U.S. LLC
Michelle McMurry-Heath, President & CEO, BIO
Joel Marcus, Executive Chairman & Founder, Alexandria Real Estate Equities, Inc./ Alexandria Venture Investments; Co-Founder, Alexandria Summit
Michel Pairet, Board of Managing Directors – Innovation, Boehringer Ingelheim
Ramona Sequeira, President, US Business Unit & Global Portfolio Commercialization, Takeda Pharmaceuticals
Pascal Soriot, CEO, AstraZeneca
Michel Vounatsos, CEO, Biogen
Lynne Zydowsky, Chief Science Officer, Alexandria Real Estate Equities, Inc. & Alexandria Venture Investments; President & Co-Founder Alexandria Summit
* as of April 18 2021
“…The right event, on the right issue at the right time…”
— Ban Ki-moon
Secretary-General, United Nations
The Galien Forum, held every autumn at New York’s Alexandria Center for Life Sciences, offers a full day of spirited discussions with Nobel Laureates, top policymakers, and leading industry executives who offer perspectives on the most significant health challenges of our time while highlighting the latest research and clinical pathways toward diagnosis, treatment, and cure.
Time and again, Forum participants praise the caliber of the speakers and their fellow attendees, the quality of the panel discussions and presentations, and the recognition of industry’s critical role in creating life-saving innovations.
Interview:
Oracle Health Sciences shares insights on sponsorship of the Prix Galien USA
A word about sponsorship
A multi-year dialogue as ambitious as the Galien Forum could not be successful without the support of forward-thinking organizations and companies. Our sponsors play a vital role in creating this historic opportunity—to bridge borders, traverse new policies, stem disease, and save lives—in the journey to transform human lives through innovation.
We are grateful for their financial support and partnership.
Download the Galien Forum App >
